Total Visits

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study224

Total Visits Per Month

March 2021April 2021May 2021June 2021July 2021August 2021September 2021
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study5371000

File Visits

Views
BriJouCan_2014n111p241.pdf2

Top country views

Views
United States129
Germany24
China6
Russia3
Spain2
France2
India2
Iran2
Italy2
Sweden2

Top cities views

Views
Woodbridge50
Fairfield24
Kiez18
Houston15
Cambridge12
Seattle7
Wilmington6
Ilmenau5
Ann Arbor3
Jacksonville3